GALAPAGOS N.V./ BE0003818359 /
4/30/2024 9:50:06 PM | Chg. -0.100 | Volume | Bid4/30/2024 | Ask4/30/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
26.520EUR | -0.38% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 1.75 bill.EUR | - | 8.28 |
GlobeNewswire
4/30
Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and E...
GlobeNewswire
4/4
Galapagos showcases innovative approach in hematological cancer care with clinical and translational...
GlobeNewswire
3/28
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
GlobeNewswire
3/26
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
GlobeNewswire
2/22
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Cl...
GlobeNewswire
1/4
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further exp...
GlobeNewswire
1/3
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule dru...
GlobeNewswire
12/22/2023
Oceana Finds China’s Fishing Fleet Swarms Galápagos, then Disappears from Sight
GlobeNewswire
12/19/2023
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufacture...
GlobeNewswire
12/9/2023
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire
12/7/2023
Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...
GlobeNewswire
11/2/2023
Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies fo...
GlobeNewswire
11/1/2023
SweetWater Brewing Company Launches Special-Edition 420 IPA in Partnership With the Georgia Aquarium...
GlobeNewswire
10/30/2023
Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business t...
GlobeNewswire
8/28/2023
Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with...
GlobeNewswire
3/24/2022
Correction: Galapagos publishes 2021 annual report and announces extraordinary and annual shareholde...